Technical Challenges and Solutions for Continuous Glucose Monitoring (CGM) Electrodes

Trend 1: Calibration-Free and Factory Calibration Technologies

Continuous glucose monitoring (CGM) is moving from professional medical devices into the consumer health-management market, with the market continuing to grow and wear durations extending from 3–7 days to 14 days or more. The first major trend is the move from "daily finger-stick calibration" to "calibration-free (factory-calibrated)" operation.

Calibration-free operation depends on two things: highly consistent electrode performance across batches, and sensors that are calibrated at the factory and maintain stable sensitivity throughout the wear period. This places unprecedented demands on electrode manufacturing — if the baseline electrochemical performance of each electrode fluctuates noticeably, no algorithmic calibration can compensate. In a sense, the race toward calibration-free CGM is largely a race for electrode batch consistency; meanwhile, the trends toward miniaturization and flexibility further amplify the value of manufacturing precision.

Four Key Technical Challenges for CGM Electrodes

Compared with disposable blood glucose test strips that are discarded after a single measurement, CGM electrodes must operate continuously in subcutaneous interstitial fluid for hundreds of hours — an order-of-magnitude increase in technical difficulty:

1. Enzyme Immobilization

Glucose oxidase must retain its activity and conformation on the electrode surface over long periods: weak immobilization causes sensitivity decay, while an overly thick layer increases response latency; the coating and cross-linking of the enzyme layer directly determine signal strength and the decay curve.

2. Interference-Rejecting Membranes

Ascorbic acid (vitamin C), acetaminophen, uric acid, and other substances in interstitial fluid generate interfering currents at the working potential. A selective membrane on the working electrode must block interferents while letting glucose/hydrogen peroxide pass, without degrading or delaminating in vivo over two weeks.

3. Long-Term Stability

After implantation, protein adsorption (biofouling) reduces sensitivity, and fibrous encapsulation from the inflammatory response alters local mass transport; substrate biocompatibility is the first line of defense.

4. Batch-to-Batch Consistency

Under a calibration-free strategy, factory calibration parameters must apply to every sensor in a batch, requiring extremely narrow batch-to-batch variation in conductivity, catalytic activity, and effective area — exactly where vacuum coating excels.

Advantages of Sputtered Precious-Metal Electrodes in CGM

Among CGM electrode material routes, magnetron-sputtered precious-metal electrodes offer clear advantages over conventional screen-printed carbon electrodes:

• Excellent biocompatibility: High-purity gold (Au ≥ 99.99%) is extremely chemically inert, reducing foreign-body reactions and protein fouling after implantation and extending the effective wear period.
• Superior batch consistency: Magnetron sputtering controls film thickness precisely at the nanoscale (±5% accuracy on Huili's production lines), so batch-to-batch differences in electrode impedance and catalytic surface area are far smaller than with screen printing — a reliable hardware foundation for calibration-free algorithms.
• High signal quality: Dense, pore-free gold films deliver low background current and low noise, keeping a good signal-to-noise ratio even at low glucose concentrations — critical for hypoglycemia alerts.
• Suited to miniaturization: Vacuum coating combined with photolithography/masking enables precise electrode patterns on tiny substrates, meeting the fabrication needs of implantable microelectrodes.
• Reliable adhesion: Sputtered films bond firmly to flexible substrates such as PI, resisting peeling during insertion, removal, and everyday bending.

Huili Biotech's CGM Electrode Solutions

Huili Biotech (Changzhou) Co., Ltd. provides R&D and mass-production services for sputtered gold electrodes targeting CGM applications. Leveraging its nanoscale magnetron sputtering vacuum coating lines, the company customizes the geometry, film thickness, and substrate combination of three-electrode systems to customer designs, with gold purity ≥99.99% and batch CV ≤5% — delivering consistent, reliable electrode hardware for calibration-free CGM products.

In terms of service model, Huili Biotech supports the full OEM/ODM process from sampling (1–2 weeks) to mass-production delivery (2–4 weeks), with an MOQ of 1,000 pieces and annual capacity over one million pieces, enabling a smooth transition from R&D validation to scaled production; stable small-batch, multi-run supply also supports teams in registration testing and clinical validation.

Outlook

The next stage for CGM is longer wear periods, multi-analyte monitoring (e.g., glucose + lactate + ketones), and less implantation trauma. Whatever the technology route, the electrode's role as the signal source will not change, and manufacturing precision and batch consistency will remain key differentiators. Huili Biotech looks forward to working closely with CGM research teams and manufacturers, empowering the next generation of continuous-monitoring products with high-precision sputtered precious-metal electrodes. Inquiries are welcome.